Intellia is a pioneer in the development of CRISPR/Cas9 genome editing and is rapidly moving experimental therapies towards the clinic.

Our company’s unique strengths include our modular lipid nanoparticle delivery system and our determined focus on product development.

Programs & Pipeline

Each one of us together for patients

We believe our modular approach to selecting our in vivo and ex vivo programs positions us to build a full-spectrum genome editing company, with a pipeline across a range of indications. This approach enables us to generate a wealth of data that opens the potential therapeutic applications of the CRISPR/Cas9 technology across a broad range of diseases.

Join Us.
See how you can change life stories with genome editing
Follow Us on Social Media
July 30, 2021

Meet Jen, Associate Scientist and member of Intellia’s Cultural Ambassadors. Jen serves on the Community Events team, which works to connect Intellia with local communities, from STEM volunteering to park clean-ups. Learn more: https://t.co/DhW4qbBFMy #OneIntellia #CRISPR https://t.co/HKa60Qy6WD

July 29, 2021

Today we are celebrating #NationalInternDay! A big thank you to our nine wonderful interns this summer for all the hard work and sharing your great ideas these past few months! #Oneintellia https://t.co/9oaIdxo6Qf